Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,816 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Eribulin in HER2 Negative Metastatic BrCa

NCT01827787

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Eastern Maine Medical Center Bangor, Maine, United States
  • Dana-Farber Cancer Institute at Faulkner Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients

NCT03013504

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Cancer, +4 more
Locations
  • Minsk Clinical Oncological Dispensary Minsk, Belarus
  • Complex Oncology Center Plovdiv, Bulgaria
  • East Tallinn Central Hospital Tallinn, Estonia
  • Centre René Huguenin (Institut Curie) Saint-Cloud, France
View all 15 locations
View Trial Details
Completed

ARRY-380 + Trastuzuamab for Breast w/ Brain Mets

NCT01921335

Conditions
Advanced HER2-positive Breast Cancer, Brain Metastases From HER2 and Breast Cancer, Breast Diseases, +5 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

NCT03726879

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • HCA Midwest Division Kansas City, Missouri, United States
  • New York University Medical Center PRIME; NYU Langone Medical Center New York, United States
  • Tennessee Oncology - Nashville Nashville, Tennessee, United States
  • Hospital Sao Rafael - HSR Salvador, Estado de Bahia, Brazil
View all 76 locations
View Trial Details

Related conditions